These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30001552)

  • 1. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
    Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
    Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
    Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
    Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer.
    Ahmed MA; Aleskandarany MA; Rakha EA; Moustafa RZ; Benhasouna A; Nolan C; Green AR; Ilyas M; Ellis IO
    Breast Cancer Res Treat; 2012 Jun; 133(3):979-95. PubMed ID: 22119938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
    Jing X; Liang H; Hao C; Yang X; Cui X
    Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of
    Strati A; Nikolaou M; Georgoulias V; Lianidou ES
    Cells; 2019 Jun; 8(7):. PubMed ID: 31261917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer.
    Cui X; Jing X; Yi Q; Long C; Tian J; Zhu J
    Oncotarget; 2017 Dec; 8(67):111444-111455. PubMed ID: 29340066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
    Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
    Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis.
    Wang Z; Wang Q; Wang Q; Wang Y; Chen J
    Int J Biol Markers; 2017 Mar; 32(1):e75-e82. PubMed ID: 27470135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.
    Deng X; Apple S; Zhao H; Song J; Lee M; Luo W; Wu X; Chung D; Pietras RJ; Chang HR
    Oncotarget; 2017 Jun; 8(24):38294-38308. PubMed ID: 28418843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer.
    Yang WJ; Shi L; Wang XM; Yang GW
    Aging (Albany NY); 2021 Aug; 13(16):20836-20852. PubMed ID: 34461608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
    Seo AN; Lee HJ; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
    Br J Cancer; 2016 May; 114(10):1109-16. PubMed ID: 27115469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Lopez-Bonet E; Menendez JA
    Oncol Rep; 2011 Jan; 25(1):135-40. PubMed ID: 21109968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.